FDA TAP Leader Departs, Oz Heads to the Hill, Global Picks, and More
In this week’s Pathways Picks: Doug Kelly leaves FDA, while the Trump administration extends buyout offers to many in the agency; Makary and Dr. Oz move closer to confirmations to lead FDA and CMS; updates from the IMDRF harmonization meeting in Tokyo, where FDA didn’t show up, but Russia’s regulators did; CMS cancels dialysis innovation model; and more from the US, Singapore, Brazil, and Europe.
Read Article